Progression to cancer in patients with confirmed dysplasia compared to dysplasia downgraded to ...

Table 1. Patient characteristics stratified by diagnosis before and after an expert pathologist review of patients with Barrett’s esophagus

Values are presented as number (%) unless otherwise indicated.

BE, Barrett’s esophagus; HGD, high-grade dysplasia; LGD, low-grade dysplasia; IND, indefinite for dysplasia; NDBE, non-dysplastic BE.

Table 2. Annual incidence rate for developing cancer and incidence rate ratios in patients with Barrett’s esophagus

IR, incidence rate; IRR, incidence rate ratio; BE, Barrett’s esophagus; HGD, high-grade dysplasia; CI, confidence interval; ref., reference; NDBE, non-dysplastic BE; IND, indefinite for dysplasia; LGD, low-grade dysplasia; NA, not applicable.

留言 (0)

沒有登入
gif